Analysis of neovascularization of PEGT/PBT-copolymer dermis substitutes in balb/c-mice

Department of Plastic and Hand Surgery, Burn Center, Department of Pathology, University Hospital Bergmannsheil, Ruhr University Bochum, Buerkle-de-la-Camp Platz 1, 44789 Bochum, Germany.
Burns (Impact Factor: 1.88). 02/2006; 32(1):35-41. DOI: 10.1016/j.burns.2005.07.009
Source: PubMed


A fundamental prerequisite for using degradable synthetic biopolymers as composite skin substitutes is the ability to establish vascular tissue. PEGT/PBT block-copolymer matrices have previously been shown as a favorable dermal substitute. In this study, quantitative data on neovascularization of PEGT/PBT block-copolymer matrices are presented.
PEGT/PBT-block-copolymer discs of three different pore diameters (1: < 75 microm, 2: 75-212 microm, 3: 250-300 microm) were implanted into dorsal skinfold chambers of balb/c mice. Histological sections were evaluated 7, 14, and 21 days post implantation by light and scanning electron microscopy. Blood vessel analysis was performed by means of digital image analysis (n = 288) of hematoxylin/eosin stained sections within apical (AOF) and basal (BOF) observation fields of the matrices.
Twenty-one days after implantation the density of blood vessels within the BOF of the scaffolds with a pore size of 75-212 and 250-300 microm were 4.6 +/- 0.45 and 5.8 +/- 0.62 (mean +/- S.E.M.; blood vessel profiles (BVF)), respectively. In <75 microm scaffolds, smaller numbers of BVF were found (4.2 +/- 0.39). In contrast, the evaluation within the AOF revealed significantly higher numbers of BVF in 75-212 microm group (3.5 +/- 0.49) and 250-300 microm group (4.5 +/- 0.66) as compared to the < 75 microm group (2.3 +/- 0.48).
There is evidence that the three-dimensional structure of PEGT/PBT-block-copolymer (pore size structure) influences neovascularization. The porous structures of copolymer matrices with adequate interconnection of pores (pore sizes of 75-212 and 250-300 microm) are characterized by faster ingrowth of vascular tissue.

14 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study examined the effects of silver-releasing wound dressing on angiogenesis and microvascularization in vivo. Implants from silver-releasing and silver-free dressings were placed into dorsal skinfold chambers of BALB/c mice. A total of 30 animals (10 implants per group) were observed. Group 1 was treated with Contreet® (Coloplast, Holtedam, Denmark). Group 2 and Group 3 were primed with Biatain™ (Coloplast, Holtedam, Denmark) and SeaSorb Soft® (Coloplast, Holtedam, Denmark). Visualization of angiogenesis and quantification of functional vessel density (FVD) was performed using intravital fluorescence microscopy (IFM). Functional vessel density served as the parameter for vascularization. Functional vessel density was measured on Day 3, 7, and 12 after implantation. Intravital fluorescence microscopy revealed constant development of a sufficient network of perfused microvessels surrounding the silver-based implants. Group 1 showed a stronger morphological alteration of microvessel network at the border zone at Day 3 and even more so at Day 7, compared to the silver-free groups. Reinforced dilatation, elongation, and torsion of capillaries with progressive growth of perfused preliminary stages of new blood vessels were observed for silver-based implants. Border zone FVD of silver-based implants at Day 3 (257.1 ± 33.9 mm/mm2) was significantly increased compared to Group 2 (230.9 ± 31.3) and Group 3 (210.2 ± 35.7). At Day 7, the FVD in Group 1 was still significantly higher as measured in Group 3 (265.9 ± 30.7 versus 219.7 ± 42.6). However, no significant difference between Groups 1 and 2 at Day 7 (265.9 ± 30.7 versus 269.4 ± 31.9) and at Day 12 (258.7 ± 38.1 versus 268.3 ± 39.0) remained. In conclusion, the silver-based implants did not show any anti-angiogenic effects when compared to the silver-free implants.
    No preview · Article · Feb 2007 · Wounds: a compendium of clinical research and practice
  • [Show abstract] [Hide abstract]
    ABSTRACT: PEGT/PBT (polyethylene glycol terephthalate/polybutylene terephthalate) copolymer matrices with three different surface coatings [calcium-phosphate (Ca-P), collagen, and gas plasma] were placed into dorsal skinfold chambers of 24 balb/c mice. Untreated PEGT/PBT matrices served as the controls. The basal surfaces of the implants directly contacted the striated skin muscle. Neovascularization of the implants was analyzed by intravital fluorescence microscopy. Microcirculatory observations were performed in the surrounding skin muscle, at the border zone of the implant, and in the center of the implant. The functional vessel density (FVD; mm/mm2), as the length of perfused microvessels per observation area, was measured by computer-assisted analysis. The FVD served as the parameter of neovascularization. At the end of the protocol, histological observation of hematoxylin/eosin-standard-stained sections was performed by light microscopy. The FVD in the center of the implant on day 8 was only observed in gas-plasma-coated (8.8 +/- 10.2 mm/mm2) and Ca-P-coated implants (0.8 +/- 2.0 mm/mm2). None of the other groups showed perfused microvessels in the center of the implant on day 8 (p < 0.05). The FVD values in the center of the gas-plasma-coated and the Ca-P-coated implants were 20.7 +/- 8.2 and 19.2 +/- 15.5 mm/mm2 as compared with 7.1 +/- 17.4 and 7.7 +/- 5.9 mm/mm2 for collagen-coated and untreated implants on day 16. The histological examination confirmed the profound microvascular ingrowth into the matrix pores of the gas-plasma-treated and the Ca-P-coated copolymer matrices in the center of the implants. The study showed that the ingrowth of microvessels into PEGT/PBT matrices can be accelerated by Ca-P coating and gas plasma treatment in the dorsal skinfold chamber in mice.
    No preview · Article · Mar 2007 · European Surgical Research
  • [Show abstract] [Hide abstract]
    ABSTRACT: In view of their pain-relieving effect, the non steroidal anti-inflammatory drugs are more and more used as a pain-reducing component in modern wound dressings. To analyse the effect on new blood vessel growth, implants from Biatain Ibu, a polyurethane foam containing ibuprofen, were inserted into the dorsal skinfold chamber of BALB/c mice. Implants from ibuprofen-free polyurethane foam Biatain served as controls (n = 10 per group). Blood vessel growth and the functional vessel density (FVD) as a parameter for microvascularization of implant's border zone were assessed by intravital fluorescence microscopy (IVFM). IVFM was performed on days 3, 7 and 12 after implantation. Direct comparison showed no significant differences in FVD (mm/mm(2)) for the border zone of the ibuprofen-releasing implants versus controls on day 3 (185.49 +/- 4.75 versus 197.17 +/- 5.21) and day 7 (229.60 +/- 8.53 versus 247.99 +/- 5.39). However, the IVFM showed a significant increased FVD for ibuprofen-releasing implants (301.30 +/- 8.44 versus 279.24 +/- 5.78) on day 12 (P < 0.05). Also, a significant increase of FVD was detected for the ibuprofen-releasing implants throughout the implantation time of 12 days. This study shows that local release of small-dose ibuprofen from a polyurethane dressing does not decrease new blood vessel growth during the implantation time of 12 days. In the end, the microvascularization of implant's border zones in both groups was found comparatively undisturbed.
    No preview · Article · Jul 2008 · International Wound Journal
Show more